Needham & Company
View Older Stories
-
Needham Reiterates Buy Rating on Rocket Lab USA (RKLB)
-
Needham Downgrades Varonis Systems (VRNS) to Hold
-
Recursion prices $200M stock offering at $3.25 per share
-
Taiwan Semi (TSM) PT Raised to $560 at Needham
-
Needham Starts CAMP4 Therapeutics Corp (CAMP) at Buy
-
Starling Oncology (STLN) PT Raised to $9 at Needham
-
Liquidia Technologies (LQDA) PT Lowered to $58 at Needham
-
Needham Reiterates Buy Rating on Workday (WDAY)
-
SentinelOne Inc (S) PT Raised to $31 at Needham
-
Synopsys (SNPS) PT Raised to $620 at Needham
-
Enovis Corp (ENOV) PT Lowered to $34 at Needham
-
Vaxcyte closes $1.15B public offering of stock and notes
-
Zeta Global Holdings Corp (ZETA) PT Raised to $40 at Needham
-
CrowdStrike (CRWD) PT Raised to $310 at Needham
-
Needham: 'Traffic Tracker: Bullish for RDDT 3Q26 User and Rev Growth'
-
Needham Reiterates Hold Rating on Elastic NV. (ESTC)
-
Needham Downgrades Pacira Pharmaceuticals (PCRX) to Hold
-
Constellation Brands (STZ) PT Lowered to $150 at Needham
-
Applied Digital (APLD) PT Lowered to $70 at Needham
-
The Elmet Group (ELMT) PT Raised to $28 at Needham
-
Everpure (P) PT Raised to $185 at Needham
-
Needham reiterates Buy rating on Alphabet with $450 target
-
Penguin Solutions shares jump on earnings beat
-
Needham Reiterates Buy Rating on Unusual Machines (UMAC)
-
Needham on Figure Technology (FIGR): 'remains our Conviction List stock'
-
Needham Reiterates Buy Rating on ServiceTitan (TTAN)
-
Marvell (MRVL) PT Raised to $400 at Needham
-
Vaxcyte prices $1B in stock and note offerings
-
Form N-CSRS NEEDHAM FUNDS INC For: Jun 30
-
Needham on HubSpot Inc (HUBS): 'anticipate additional upside to margins'
-
Needham: 'we believe that Stiles is a known entity to investors and well prepared to lead SYK'
-
Needham Reiterates Buy Rating on Upstart Holdings Inc (UPST)
-
Neogenomics (NEO) PT Raised to $22 at Needham
-
Needham Reiterates Buy Rating on Upstart Holdings Inc (UPST)
-
Needham Reiterates Buy Rating on Better Home & Finance Holding (BETR)
-
Needham Reiterates Buy Rating on AppLovin Corp (APP)
-
Needham Starts Standard Nuclear (STDN) at Buy
-
Vaxcyte launches $1B in dual public offerings of stock and notes
-
Vaxcyte (PCVX) PT Raised to $122 at Needham
-
Needham Reiterates Buy Rating on GE HealthCare (GEHC)
-
Needham Reiterates Buy Rating on Workday (WDAY)
-
Shattuck Labs (STTK) PT Raised to $19 at Needham
-
Needham Starts LB Pharmaceuticals Inc (LBRX) at Buy
-
Candel Therapeutics publishes phase 2a NSCLC trial data in peer-reviewed journal
-
Veritone launches $15M registered direct offering of common stock
-
Vicor Corporation (VICR) PT Raised to $350 at Needham
-
Needham Starts Freshpet (FRPT) at Hold
-
Needham Reiterates Hold Rating on Apple (AAPL), 'META Wants a Big Bite of AAPL'
-
Needham Reiterates Buy Rating on ZoomInfo Technologies (GTM)
-
Needham Reiterates Hold Rating on Meta Platforms Inc. (META)


